← QUEST DIAGNOSTICS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $645.0m | $772.0m | $736.0m | $858.0m | $1.4b | $2.0b | $946.0m | $854.0m | $871.0m | $992.0m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $642.0m | $769.0m | $733.0m | $906.0m | $1.5b | $2.1b | $1.0b | $908.0m | $921.0m | $1.0b | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $696.0m | $824.0m | $788.0m | $906.0m | $1.5b | $2.1b | $1.0b | $908.0m | $921.0m | $1.0b | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $645.0m | — | — | $838.0m | $1.4b | $2.0b | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $696.0m | — | — | $886.0m | $1.5b | $2.1b | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $0 | — | — | $20.0m | $0 | $0 | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $0 | — | — | $20.0m | $0 | $0 | — | — | — | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $51.0m | $52.0m | $52.0m | $48.0m | $68.0m | $85.0m | $69.0m | $54.0m | $50.0m | $54.0m | |
| Depreciation, Depletion and Amortization | $249.0m | $270.0m | $309.0m | $329.0m | $361.0m | $408.0m | $437.0m | $439.0m | $493.0m | $570.0m | |
| Depreciation | $177.0m | $196.0m | $219.0m | $233.0m | $258.0m | $305.0m | $317.0m | $331.0m | $366.0m | $416.0m | |
| Amortization of Intangible Assets | $72.0m | $74.0m | $90.0m | $96.0m | $103.0m | $103.0m | $120.0m | $108.0m | $127.0m | $154.0m | |
| Deferred Income Tax Expense (Benefit) | $37.0m | $9.0m | $73.0m | $15.0m | $85.0m | ($57.0m) | $1.0m | ($49.0m) | $13.0m | $105.0m | |
| Share-based Payment Arrangement, Noncash Expense | $69.0m | $79.0m | $61.0m | $56.0m | $97.0m | $79.0m | $77.0m | $77.0m | $88.0m | $88.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $10.0m | $23.0m | $21.0m | $16.0m | $15.0m | $22.0m | $28.0m | $28.0m | $24.0m | $45.0m | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | — | $0 | $0 | $0 | |
| Impairment of Intangible Assets (Excluding Goodwill) | $7.0m | — | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Disposition of Business | $118.0m | $0 | ($4.0m) | — | — | — | — | — | — | — | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | — | $70.0m | ($3.0m) | ($9.0m) | — | — | — | — | |
| Income (Loss) from Equity Method Investments | $39.0m | $35.0m | $44.0m | $57.0m | $75.0m | $78.0m | $44.0m | $26.0m | $19.0m | $42.0m | |
| Income Tax Expense (Benefit) | $429.0m | $241.0m | $182.0m | $247.0m | $460.0m | $597.0m | $264.0m | $248.0m | $273.0m | $314.0m | |
| Other Nonoperating Income (Expense) | ($48.0m) | $16.0m | ($8.0m) | $20.0m | $76.0m | $369.0m | ($55.0m) | $20.0m | $30.0m | $26.0m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $343.0m | $298.0m | $65.0m | $63.0m | $455.0m | ($81.0m) | ($246.0m) | $15.0m | $71.0m | $106.0m | |
| Proceeds from Stock Options Exercised | $73.0m | $130.0m | $99.0m | $119.0m | $189.0m | $129.0m | $123.0m | $72.0m | $73.0m | $79.0m | |
| Equity Securities, FV-NI, Gain (Loss) | — | — | — | $10.0m | $8.0m | $56.0m | ($55.0m) | $20.0m | $18.0m | $19.0m | |
| Goodwill | $6.0b | $6.3b | $6.6b | $6.6b | $6.9b | $7.1b | $7.2b | $7.7b | $8.9b | $8.9b | |
| Nonoperating Income (Expense) | ($191.0m) | ($135.0m) | ($175.0m) | ($155.0m) | ($87.0m) | $218.0m | ($193.0m) | ($132.0m) | ($171.0m) | ($238.0m) | |
| Other Operating Income (Expense), Net | $13.0m | ($1.0m) | $14.0m | $95.0m | ($9.0m) | $2.0m | ($11.0m) | ($41.0m) | ($1.0m) | $12.0m | |
| Net Cash Provided by (Used in) Operating Activities | $1.1b | $1.2b | $1.2b | $1.2b | $2.0b | $2.2b | $1.7b | $1.3b | $1.3b | $1.9b | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $293.0m | $252.0m | $383.0m | $400.0m | $418.0m | $403.0m | $404.0m | $408.0m | $425.0m | $527.0m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $139.0m | $581.0m | $421.0m | $58.0m | $330.0m | $331.0m | $144.0m | $611.0m | $2.2b | $101.0m | |
| Payments for (Proceeds from) Other Investing Activities | ($10.0m) | ($2.0m) | ($1.0m) | $44.0m | $27.0m | $3.0m | ($5.0m) | $42.0m | ($41.0m) | $3.0m | |
| Net Cash Provided by (Used in) Investing Activities | ($152.0m) | ($805.0m) | ($801.0m) | ($411.0m) | ($772.0m) | $21.0m | ($543.0m) | ($1.1b) | ($2.5b) | ($631.0m) | |
| Cash flows from financing activities: | |||||||||||
| Payments for Repurchase of Common Stock | $590.0m | $465.0m | $322.0m | $353.0m | $325.0m | $2.2b | $1.4b | $275.0m | $151.0m | $450.0m | |
| Payments of Ordinary Dividends, Common Stock | $223.0m | $247.0m | $266.0m | $286.0m | $297.0m | $309.0m | $305.0m | $314.0m | $331.0m | $353.0m | |
| Proceeds from Noncontrolling Interests | $0 | $4.0m | $16.0m | $0 | $0 | — | — | — | — | — | |
| Dividends Payable, Current | $62.0m | $61.0m | $71.0m | $71.0m | $76.0m | $74.0m | $74.0m | $79.0m | $84.0m | $89.0m | |
| Dividends Payable | $62.0m | $61.0m | $71.0m | $71.0m | $76.0m | $74.0m | $74.0m | $79.0m | $84.0m | $89.0m | |
| Proceeds from (Payments for) Other Financing Activities | ($45.0m) | $40.0m | $23.0m | ($17.0m) | $44.0m | ($38.0m) | ($39.0m) | $14.0m | $21.0m | $39.0m | |
| Net Cash Provided by (Used in) Financing Activities | ($691.0m) | ($592.0m) | ($401.0m) | $225.0m | ($1.3b) | ($2.5b) | ($1.7b) | $160.0m | $1.1b | ($1.4b) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | $0 | $0 | ($7.0m) | $4.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | — | — | $0 | $371.0m | ($137.0m) | ($129.0m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $135.0m | $1.2b | $1.2b | $872.0m | $315.0m | $686.0m | $549.0m | $420.0m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | — | — | $159.0m | $156.0m | $134.0m | $262.0m | $280.0m | |
| Income Taxes Paid, Net | — | — | — | — | — | — | — | — | — | $169.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.